GlassScriptPhysician profile
Fernando O Recio
NPI 1245227818
$27,695.19
in general payments reported to CMS, 2019-2025
39 companies · $1,882 in 2025
The $1,882 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $884 · 2020: $128 · 2021: $4,446 · 2022: $8,721 · 2023: $6,122 · 2024: $5,512 · 2025: $1,882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,233 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,900 · Consulting Fee: $3,260 · Travel and Lodging: $567 · Education: $546 · Gift: $9.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,233.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,900.00 |
| Consulting Fee | $3,260.00 |
| Travel and Lodging | $567.00 |
| Education | $545.82 |
| Gift | $9.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $19,656.16 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,379.61 | 2019-2025 | Lynparza, Imfinzi |
| Glaxosmithkline, LLC. | $1,291.61 | 2021-2025 | Jemperli, Zejula |
| Intuitive Surgical, INC. | $799.08 | 2019-2025 | Da Vinci Surgical System |
| Seagen INC. | $702.14 | 2021-2023 | Tivdak |
| Tempus Ai, INC | $599.63 | 2024-2025 | Xt Cdx |
| Merck Sharp & Dohme LLC | $591.57 | 2019-2025 | Lynparza, Keytruda, Keytruda Qlex |
| Pfizer INC. | $580.56 | 2024-2025 | |
| Abbvie INC. | $339.21 | 2019-2025 | |
| Biom'Up France Sas | $238.37 | 2021 | |
| Stryker Corporation | $125.42 | 2019 | |
| Coopersurgical, INC. | $111.41 | 2024-2025 | Ally II Ups, Advincula Delineator Uterine Manipulator |
| Integra Lifesciences Corporation | $110.42 | 2023 | Biodfactor, Biofix, Medihoney |
| Astellas Pharma US INC | $98.64 | 2024-2025 | Veozah |
| Myriad Genetic Laboratories, INC. | $97.34 | 2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $87.59 | 2019 | |
| Caris Mpi, INC. | $86.08 | 2025 | Mi Cancer Seek |
| Bayer Healthcare Pharmaceuticals INC. | $83.55 | 2019-2024 | |
| Therapeuticsmd, INC. | $81.73 | 2019 | |
| Sumitomo Pharma America, INC. | $72.04 | 2023-2025 | Myfembree |
| Shield Therapeutics INC | $61.87 | 2023-2025 | Accrufer |
| Davol INC. | $57.25 | 2021 | |
| Coherus Oncology, INC. | $55.02 | 2021-2022 | |
| Verastem, INC. | $49.00 | 2025 | Avmapki Fakzynja Co-Pack |
| Mayne Pharma Commercial LLC | $34.86 | 2023 | |
| Conmed Corporation | $34.28 | 2024 | Airseal |
| Immunogen, INC. | $27.22 | 2023 | Elahere |
| Sobi, INC | $25.10 | 2022 | |
| Lsi Solutions INC | $24.10 | 2023 | Fornisee |
| Hologic Sales and Service, LLC | $22.94 | 2022 | |
| Ethicon US, LLC | $22.56 | 2019 | |
| Idorsia Pharmaceuticals US INC | $21.76 | 2022 | |
| Tesaro, INC. | $21.54 | 2019 | |
| Amneal Pharmaceuticals LLC | $21.21 | 2023 | Neulasta, Neupogen, Avastin |
| Novocure INC. | $21.18 | 2025 | Optune Gio |
| Clovis Oncology, INC. | $19.81 | 2022 | |
| Novo Nordisk INC | $16.46 | 2023 | Wegovy |
| Axonics, INC. | $14.39 | 2023 | Axonics |
| Amgen INC. | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Recio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.